DPYSL3 and breast carcinoma: For example, in dihydropyrimidinase-like 3 (DPYSL3)-positive breast cancer CLOW cells, cell proliferation decreases and the expression of marker genes in epithelial-mesenchymal transformation increases in the DPYSL3 knockdown group.